| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |